Business Wire
14 Aug 2026, 23:47 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
A class action lawsuit has been filed against Aardvark Therapeutics (NASDAQ: AARD) by shareholders who acquired stock between February 13, 2025, and May 14, 2026. — Securities class actions typically signal legal risk, potential financial liabilities, and concerns over the accuracy of company disclosures.
-0.60Which stocks this story touches
The company is facing a class action lawsuit related to its IPO and subsequent securities offerings.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
12h ago
